1. Repurposing of metabolic drugs and mitochondrial modulators as an emerging class of cancer therapeutics with a special focus on breast cancer
   Versha Tripathi et al, 2022, Advances in Cancer Biology - Metastasis CrossRef
2. Importance of Mevalonate Pathway Lipids on the Growth and Survival of Primary and Metastatic Gastric Carcinoma Cells
   Natalia Ortiz et al, 2021, Clinical and Experimental Gastroenterology CrossRef
3. Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications
   Alfonso Duenas-Gonzalez et al, 2022, Current Cancer Drug Targets CrossRef
4. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
   Marina Leite et al, 2023, Hereditary Gastric and Breast Cancer Syndrome CrossRef
5. Repositioning of HMG-CoA Reductase Inhibitors as Adjuvants in the Modulation of Efflux Pump-Mediated Bacterial and Tumor Resistance
   Zsuzsanna Schelz et al, 2023, Antibiotics CrossRef
6. Statins: a repurposed drug to fight cancer
   Wen Jiang et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
7. BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal
   Adriana Romo-Perez et al, 2022, Current Molecular Pharmacology CrossRef
8. Repurposed Drugs in Gastric Cancer
   Diana Araújo et al, 2022, Molecules CrossRef
9. The Role of Lipid Metabolism in Gastric Cancer
   Meng-Ying Cui et al, 2022, Frontiers in Oncology CrossRef